Real World Experience of Standard of Care Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma

被引：0

作者：

Grajales-cruz, Ariel ^{[1
]}

Graeter, Allison ^{[2
]}

Hansen, Doris ^{[1
]}

Puglianini, Omar Castaneda ^{[1
]}

Vazquez-Martinez, Mariola ^{[1
]}

Blue, Brandon ^{[1
]}

Liu, Hien ^{[1
]}

Ochoa-Bayona, Jose ^{[1
]}

Freeman, Ciara ^{[1
]}

Locke, Frederick ^{[1
]}

Nishihori, Taiga ^{[1
]}

Shain, Kenneth ^{[1
]}

Baz, Rachid ^{[1
]}

Alsina, Melissa ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Univ S Florida, Tampa, FL 33620 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-027

引用

页码：S56 / S56

页数：1

共 50 条

[1] A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/ Refractory Multiple Myeloma
Frenking, Jan
Riedhammer, Christine
Besemer, Britta
Braune, Jan
Brioli, Annamaria
Brunner, Franziska
Dampmann, Maria
Gezer, Deniz
Goldman-Mazur, Sarah
Haenel, Mathias
Hanoun, Christine
Hoegner, Marion
Kolditz, Katja
Kos, Igor
Kull, Miriam
Leitner, Theo
Merz, Maximilan
von Metzler, Ivana
Michel, Christian S.
Teipel, Raphael
Theurich, Sebastian
Waesch, Ralph
Zukovs, Romans
Rasche, Leo
Raab, Marc-Steffen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S52 - S53
[2] Real world Experience of Talquetamab in Relapsed Refractory Myeloma, First Report From the IMWG Consortium
Janakiram, Murali
Tan, Carlyn
Popat, Rakesh
Kastritis, Efstathios
Martinez-Lopez, Joaquin
Shekarkhand, Tala
Bansal, Radhika
Corraes, Andre De Menezes Silva
Corona de la Puerta, Magdalena
Saez Marin, Adolfo J.
Htut, Myo
Fotiou, Despina
Dimopoulos, Meletios
Chowdhury, Arnab
Kumar, Shaji
Martin, Thomas
Krishnan, Amrita
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S60 - S61
[3] Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
Shaikh, Hira
Lochner, Jonathan
Friend, Reed
Snyder, Jordan
Davis, James
Patrus, Gina
Dileo, Rachel
Ahmed, Nausheen
Mewawalla, Prerna
Poonsombudlert, Kittika
Struble, Emily
Wolcott, Allyson
Green, Kimberly
Sparrow, Samantha
Mushtaq, Muhammad Umair
Paul, Barry
Abdallah, Al-Ola
Strouse, Christopher
Hashmi, Hamza
Atrash, Shebli
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S87 - S88
[4] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
Costa, Bruno
Tan, Carlyn
Shekarkhand, Tala
Firestone, Ross
Jurgens, Eric
Miller, Kevin
Lesokhin, Alexander
Shah, Gunjan
Korde, Neha
Rajeeve, Sridevi
Chung, David
Landau, Heather
Scordo, Michael
Hassoun, Hani
Maclachlan, Kylee
Shah, Urvi
Hultcrantz, Malin
Hamadeh, Issam
Giralt, Sergio
Mailankody, Sham
Usmani, Saad
Hashmi, Hamza
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S46 - S47
[5] Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experience
Fucci, Ludovica
Gensini, Lorenzo
Coppetelli, Ugo
La Barbera, Elettra Ortu
Gentile, Martina
Fiori, Luciano
Perrone, Salvatore
Cimino, Giuseppe
LEUKEMIA RESEARCH REPORTS, 2022, 17
[6] Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
Chari, Ajai
Krishnan, Amrita
Rasche, Leo
Ye, Jing Christine
Garfall, Alfred
Popat, Rakesh
Lipe, Brea
Qin, Xiang
Campagna, Michela
Masterson, Tara
Tomlinson, Chalmer
Hilder, Brandi
Tolbert, Jaszianne
Renaud, Thomas
Smit, M. Damiette
Gray, Kathleen
Kane, Colleen
Heuck, Christoph
van de Donk, Niels W. C. J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10) : 665 - +
[7] NURSING CONSIDERATIONS FOR TALQUETAMAB DOSING IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Blazquez, Patricia
Chari, Ajai
Renaud, Thomas
Tolbert, Jaszianne
Gray, Kathleen
Catamero, Donna
ONCOLOGY NURSING FORUM, 2024, 51 (02)
[8] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
Hultcrantz, Malin
Orozco, Jennifer
Peterson, Tim J.
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Lu, Sydney X.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Maclachlan, Kylee H.
Chung, David J.
Landau, Heather J.
Shah, Gunjan L.
Lahoud, Oscar B.
Scordo, Michael
Landgren, Ola
Giralt, Sergio
Lesokhin, Alexander
BLOOD, 2021, 138
[9] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
Costa, Bruno Almeida
Tan, Carlyn Rose
Shekarkhand, Tala
Firestone, Ross S.
Jurgens, Eric M.
Miller, Kevin
Lesokhin, Alexander M.
Shah, Gunjan L.
Korde, Neha
Rajeeve, Sridevi
Chung, David J.
Landau, Heather J.
Scordo, Michael
Hassoun, Hani
Maclachlan, Kylee H.
Shah, Urvi A.
Hultcrantz, Malin
Hamadeh, Issam S.
Giralt, Sergio
Mailankody, Sham
Usmani, Saad Z.
Hashmi, Hamza
BLOOD, 2024, 144 : 7026 - 7027
[10] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Cohen, Yael C.
Magen, Hila
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Ocio, Enrique M.
Yoon, Sung-Soo
Chu, Michael P.
Rodriguez-Otero, Paula
Avivi, Irit
Quijano Carde, Natalia A.
Kumar, Ashwini
Krevvata, Maria
Peterson, Michelle R.
Di Scala, Lilla
Scott, Emma
Hilder, Brandi
Vanak, Jill
Banerjee, Arnob
Oriol, Albert
Morillo, Daniel
Mateos, Maria-Victoria
NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02) : 138 - 149

← 1 2 3 4 5 →